Nxera Pharma Co., Ltd. (OTCMKTS:SOLTF) Short Interest Update

by · The Markets Daily

Nxera Pharma Co., Ltd. (OTCMKTS:SOLTF – Get Free Report) saw a large decline in short interest during the month of September. As of September 15th, there was short interest totalling 2,006,700 shares, a decline of 16.6% from the August 31st total of 2,405,300 shares. Based on an average daily trading volume, of 100 shares, the days-to-cover ratio is currently 20,067.0 days.

Nxera Pharma Stock Performance

OTCMKTS SOLTF opened at $9.15 on Monday. Nxera Pharma has a 52-week low of $8.22 and a 52-week high of $13.43. The company has a 50-day simple moving average of $9.55 and a 200 day simple moving average of $9.74.

Nxera Pharma Company Profile

(Get Free Report)

Nxera Pharma Co, Ltd. develops and sells biopharmaceutical products in Japan, Switzerland, the United States, Bermuda, and the United Kingdom. Its product portfolio products include Ultibro/Breezhaler and Seebri/Breezhaler for the treatment of chronic obstructive pulmonary disease; Enerzair and Breezhaler for the treatment of asthma; ORAVI, a novel formulation for the treatment of oropharyngeal candidiasis; and PIVLAZ for the treatment of cerebral vasospasm indications.

Read More